Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,505 | 6,178 | 3,807 | 3,125 | 2,750 |
| TOTAL | $10,505 | $6,178 | $3,807 | $3,125 | $2,750 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1 |
| Total Assets | $10,505 | $6,178 | $3,807 | $3,125 | $2,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,509 | 4,875 | 1,109 | 1,297 | 1,048 |
| Other current liabilities | 52 | 277 | 207 | 83 | 84 |
| TOTAL | $5,235 | $5,825 | $1,622 | $1,686 | $1,439 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 674 | 674 | 306 | 306 | 306 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,235 | $5,825 | $1,622 | $1,686 | $1,439 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,678 | 14,678 | 13,855 | 13,630 | 13,368 |
| Common Shares | 15 | 14 | 14 | 14 | 13 |
| Retained earnings | -92,794 | -87,137 | -77,589 | -73,437 | -69,412 |
| TOTAL | $5,270 | $353 | $2,185 | $1,440 | $1,312 |
| Total Liabilities And Equity | $10,505 | $6,178 | $3,807 | $3,125 | $2,751 |